AgEagle Aerial Systems Inc.
Business
AgEagle Aerial Systems Inc. designs and delivers advanced uncrewed aerial systems that integrate flight hardware, sensors and software to address operational needs across commercial and government customers. Its product offerings include fixed‑wing eBee UAS (including tactical and ISR variants), high‑resolution thermal and multispectral sensors (Altum‑PT, RedEdge‑P series) and flight management and data analytics software. The company reports operations across three primary segments — drones, sensors and software — and owns subsidiaries including senseFly and MicaSense. It serves global markets such as military/defense, public safety, surveying/mapping, agriculture and utilities through direct sales and a global reseller network, with manufacturing in the U.S. and Switzerland.
Summary from filing dated 2025-03-31
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenues | 13 | 13 | — | — | — | |
| Cost of sales | 6 | 7 | 8 | 11 | 6 | |
| Gross profit | 7 | 6 | 5 | 8 | 4 | |
| General and administrative | 9 | 10 | 14 | 18 | 15 | |
| Research and development | 4 | 4 | 6 | 8 | 4 | |
| Sales and marketing | 3 | 2 | 4 | 5 | 3 | |
| Asset Impairment Charges | 6 | 3 | 22 | 42 | — | |
| Total operating expenses | 21 | 19 | 45 | 72 | 35 | |
| Loss from operations | −15 | −13 | −39 | −64 | −30 | |
| Interest expense | −9,593 | −8 | — | — | — | |
| Loss on debt extinguishment | −125,242 | −2 | −2 | 6 | 0 | |
| Loss on equity financing | 0 | −15 | — | — | — | |
| Gain on change in fair value of warrant liabilities | 9 | 3 | — | — | — | |
| Gain (loss) on disposal of fixed assets | −1,385 | 13,522 | — | −25,960 | −3,712 | |
| Other income (expense), net | 1 | −247,759 | — | — | 87,124 | |
| Total other income (expense), net | 9 | −22 | −3 | 6 | 184,092 | |
| Net loss before provision for income taxes | −5 | −35 | −42 | −58 | −30 | |
| Provision for income taxes | 0 | 0 | — | — | 0 | |
| Net loss | −5 | −35 | −42 | −58 | −30 | |
| Accrued dividends on Series F Preferred Stock | −201,867 | −234,439 | — | — | — | |
| Deemed dividends on Series F and G Preferred Stock and Warrants | −8 | −18 | — | — | — | |
| Net loss attributable to common stockholders | −13 | −53 | −54 | — | — | |
| Net loss per common share - Basic and Diluted (in dollars per share) | −0.52 | −46.24 | −514.9 | −13.97 | — | |
| Weighted average number of shares outstanding during the period Basic and Diluted (in shares) | 25 | 1 | 105,592 | 4 | — | |
| Amortization of unrecognized periodic pension costs | 16,012 | 10,246 | — | — | — | |
| Foreign currency cumulative translation adjustment | 261,549 | −202,925 | — | — | — | |
| Total comprehensive loss, net of tax | −5 | −35 | −42 | −58 | −30 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash | 30 | 4 | — | — | — | |
| Accounts receivable, net | 3 | 1 | 2 | 2 | 3 | |
| Inventories, net | 6 | 5 | 7 | 7 | 4 | |
| Prepaid and other current assets | 556,655 | 425,182 | 548,561 | 1 | — | |
| Total current assets | 40 | 11 | 11 | 14 | 23 | |
| Property and equipment, net | 331,818 | 455,592 | 799,892 | 791,155 | 952,128 | |
| Right-of-use assets | 2 | 3 | 4 | 4 | 2 | |
| Intangible assets, net | 56,850 | 2 | 3 | 12 | 14 | |
| Goodwill | 0 | 4 | 7 | 23 | 65 | |
| Other assets | 444,481 | 250,937 | — | — | — | |
| Total assets | 42 | 21 | 25 | 54 | 105 | |
| Accounts payable | 2 | 3 | 3 | 2 | 3 | |
| Accrued liabilities | 2 | 2 | 2 | 2 | — | |
| Convertible note | 0 | 1 | 5 | — | — | |
| Other short-term loan | 0 | 99,735 | — | — | — | |
| Contract liabilities | 127,874 | 148,054 | 226,316 | 496,390 | 971,140 | |
| Current portion of lease liabilities | 849,599 | 921,038 | 901,925 | 628,113 | 1 | |
| Total current liabilities | 5 | 8 | 11 | 5 | 17 | |
| Long-term portion of lease liabilities | 1 | 2 | 3 | 3 | 942,404 | |
| Long-term portion of COVID loan | 209,563 | 274,389 | 489,037 | 446,813 | 808,021 | |
| Warrant liabilities | 50,000 | 16 | — | — | — | |
| Defined benefit plan obligation | 215,021 | 115,355 | — | — | — | |
| Total liabilities | 6 | 26 | 14 | 11 | 28 | |
| COMMITMENTS AND CONTINGENCIES (NOTE 13) | — | — | — | — | — | |
| Common Stock, $0.001 par value, 200,000,000 shares authorized as of December 31, 2025 and December 31,2024, respectively, 43,613,800 and 9,661,664 shares issued and outstanding as of December 31, 2025 and 2024 respectively | 43,614 | 9,662 | 141 | 88,467 | 75,315 | |
| Additional paid-in capital | 267 | 213 | 176 | 155 | 128 | |
| Accumulated deficit | −231 | −218 | −166 | −112 | −51 | |
| Accumulated other comprehensive income (loss) | 191,185 | −86,376 | 106,303 | 10,083 | −70,594 | |
| Total stockholders equity (deficit) | 36 | −6 | 11 | 43 | 77 | |
| Total liabilities and stockholders equity (deficit) | 42 | 21 | 25 | 54 | 105 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Goodwill and Intangible impairment | 6 | 3 | — | — | — | |
| Stock-based compensation | 417,747 | 80,606 | 1 | 3 | 5 | |
| Depreciation and amortization | 809,731 | 1 | 4 | 4 | 2 | |
| Defined benefit plan obligation and other | −82,877 | −88,777 | — | — | — | |
| Interest added to convertible note payable | 0 | 1 | — | — | — | |
| Interest expense for reduction in convertible note conversion price | 0 | 6 | — | — | — | |
| Amortization of debt discount and warrant modification | 35,265 | 1 | — | — | — | |
| Accounts receivable | −2 | 593,038 | 223,457 | 637,156 | 514,265 | |
| Inventories | −160,734 | 1 | 53,178 | −3 | −2 | |
| Prepaid expenses and other current assets | 286,520 | 199,652 | 543,703 | 230,688 | −218,493 | |
| Accounts payable | −1 | −281,367 | 1 | −681,556 | 552,741 | |
| Accrued liabilities and other liabilities | −45,729 | 185,000 | 44,499 | −716,960 | −3 | |
| Contract liabilities | −112,274 | −74,215 | −280,685 | −472,604 | 393,521 | |
| Other | 0 | 185,000 | — | — | — | |
| Net cash used in operating activities | −10 | −7 | −11 | −20 | −12 | |
| Purchases of property and equipment | −74,658 | −49,485 | −215,357 | −313,769 | −525,312 | |
| Proceeds from the sale of property and equipment | 0 | 27,510 | — | — | — | |
| Capitalization of internal-use software costs | 0 | −72,102 | — | — | −278,264 | |
| Net cash used in investing activities | −74,658 | −94,077 | −776,970 | −8 | −42 | |
| Proceeds from the sale of Common Stock and warrant liabilities | 0 | 6 | — | — | — | |
| Payments on convertible note | 0 | −4 | — | — | — | |
| Repayments on other short-term loan | −135,000 | −1 | — | — | — | |
| Net cash provided by financing activities | 36 | 10 | 9 | 18 | 46 | |
| Net change in cash | 26 | 3 | −4 | −10 | −9 | |
| Effects of foreign exchange rates on cash flows | 72,875 | −80,405 | — | — | — | |
| Interest cash paid | 35,265 | 2 | — | 7,590 | 0 | |
| Income taxes paid | 0 | 0 | — | — | — | |
| Accrued expense settled with Series B Warrant exercise | 350,000 | 0 | — | — | — |